Skip to content
10-Q

Quarterly Report

VIVEON HEALTH ACQUISITION CORP.

0001493152-24-022955

← back to feed
Filed
Jun 6, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jun 6, 2024 5.66M sh
Shares Diluted Q1 2023 · Mar 31, 2023 5.87M sh
Shares Diluted Q1 2023 · Mar 31, 2022 21.97M sh
Stock Repurchased Q1 2023 · Mar 31, 2023 $34M
Stock Repurchased Q1 2023 · Mar 31, 2022 $152.45M
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$173.99K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$433.62K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $77.86K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $19.85K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$15.94M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$16.2M
Stockholders Equity restated Q1 2023 · Mar 31, 2022 −$15.31M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$12.99M
Current Liabilities Q1 2023 · Mar 31, 2023 $7.84M
Current Liabilities Q1 2023 · Dec 31, 2022 $41.03M
Total Liabilities Q1 2023 · Mar 31, 2023 $16.98M
Total Liabilities Q1 2023 · Dec 31, 2022 $50.71M
Current Assets Q1 2023 · Mar 31, 2023 $82.86K
Current Assets Q1 2023 · Dec 31, 2022 $68.57K
Total Assets Q1 2023 · Mar 31, 2023 $20.56M
Total Assets Q1 2023 · Dec 31, 2022 $53.92M
Eps Diluted Q1 2023 · Mar 31, 2023 $0.04
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.07
Eps Basic Q1 2023 · Mar 31, 2023 $0.04
Eps Basic Q1 2023 · Mar 31, 2022 −$0.07
Net Income Q1 2023 · Mar 31, 2023 $262.93K
Net Income restated Q1 2023 · Mar 31, 2022 −$1.61M
Operating Income Q1 2023 · Mar 31, 2023 −$595.82K
Operating Income restated Q1 2023 · Mar 31, 2022 −$1.16M